The surveillance of (emerging) wildlife diseases can provide important, objective evidence of the circulation of pathogens of interest for veterinary and/or public health. The involvement of multiple research institutions in wildlife disease surveillance can ensure the best use of existing knowledge and expertise, but can also complicate or add challenges to the integration of wildlife disease
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Introduction
Wildlife serves as an important reservoir for infectious agents that cause (emerging) infectious diseases (1, 2) . Many pathogens and toxins that cause wildlife diseases are also a potential risk to public health, to the health of domesticated animals and/or to the survival of the wildlife population itself -thus also posing a potential ecological risk. The surveillance of infectious organisms in wildlife can provide important, objective evidence of the circulation of pathogens that are significant for veterinary or public health. In the Netherlands, 86 emerging zoonoses have been ranked, using a risk score based on seven weighted criteria. One outcome of this action has been recognition of the importance of wildlife, since 85% of the 86 prioritised pathogens are related to wildlife (3, 4) .
As a result of the large array of agents that can affect or infect wildlife, their various characteristics, and the multiple species This overview will be especially of interest to colleagues working on wildlife diseases, to facilitate national and international collaboration, as well as to policy-makers and veterinary authorities who wish to evaluate or restructure the organisation of their wildlife disease research. The documentation of existing national efforts for the surveillance of wildlife diseases is a crucial first step for such a task.
In this paper, the authors use the term 'wildlife disease surveillance' to cover surveillance of both diseases and their causative (non-) infectious pathogens. These pathogens, including vector-borne pathogens, may cause disease in wildlife, or have wildlife as their reservoir and cause disease in either domestic animals and/or humans. 
Wildlife disease surveillance in the Netherlands
The flow charts in Figure 1a to Figure The surveillance of specific pathogens in wild boar ( Fig. 1a ) has been continuing for decades, as they are a reservoir for various pathogens that may affect the pig-farming industry. As wild boar are also hunted for meat, additional regulations are in place for approving the meat for consumers. Although Mycobacterium bovis is emerging in wild boar in some European countries, e.g. France (7), Dutch policy-makers are still discussing whether M. bovis should be included in a targeted surveillance system, since it has not yet been detected in the Netherlands. Testing wild boar for foot and mouth disease virus and swine vesicular disease virus was discontinued in 2015.
The flow chart of wild carnivores (Fig. 1b) Surveillance of various small rodent species (Fig. 1c) The causes of death or disease in hares (Lepus europaeus) and rabbits (Oryctolagus cuniculus) are investigated at the DWHC (Fig. 1e) .
From 2011 to 2015, spleens and livers of hares that had been hunted or found dead, but were not considered suitable for consumption, were routinely submitted to the WBVR and analysed for the presence of (Fig. 1f) .
Targeted surveillance is carried out on birds for avian influenza. In cases of mortality in a single area above the threshold (>3 dead water birds, or >20 birds other than water birds), the NVWA collects the dead birds, which are subsequently tested for avian influenza virus at the WBVR. Pharyngeal and cloacal swabs from live birds, predominantly ducks, geese and gulls, are analysed for avian influenza at the Erasmus MC in Rotterdam, which also coordinates the capture of these birds. A blood sample is taken from a proportion of the birds. (9) and live, stranded cetaceans; viral diseases such as influenza (10) and phocine distemper (11, 12); and bacterial diseases such as staphylococcosis (13) . 
Key features of current surveillance systems in the Netherlands
Key to wildlife disease surveillance programmes in the Netherlands is the close collaboration among the various institutes, which provides strong links between wildlife health, human health, companion animal this and any potential action were discussed in the forum, resulting in communications aimed at veterinarians and general practitioners in this part of the country. There are no strict guidelines on decisionmaking, and it is the responsibility of the partners of the SOZ to decide on any potential follow-up. When a notifiable animal disease is suspected, the Netherlands Food and Consumer Product Safety Authority, which includes the Dutch Veterinary Services, is contacted immediately and (European) legislation is then followed.
Collaboration between the institutes described above is crucially important; however, they also need to collaborate with related institutes that take an interest in wildlife from other (ecological) perspectives. Combining knowledge of pathogens in wildlife populations with knowledge of other aspects of wildlife populations, such as their numbers, distribution, and ecology, is vital when risk assessments for wildlife diseases must be performed. In the Netherlands, the DWHC is the primary partner, bridging the gap between disease knowledge and ecosystem knowledge by initiating close collaborations with diverse institutes that have ecological expertise. These can range from collaborative research projects to organising training for hunters in wildlife diseases and hygiene.
Another limitation to the involvement of multiple research institutes is that resources for wildlife surveillance must be divided among the institutes concerned, which complicates the re-allocation of resources when this proves necessary, e.g. in the case of an emerging disease.
On the other hand, the involvement of expert institutes in various components of surveillance may also reduce costs, as surveillance can be incorporated into the other activities of the institutes.
The current budgets for targeted and long-term surveillance programmes may not be sufficient to respond to newly introduced pathogens, for instance, the need to test for new pathogens using stored samples or to take additional samples during post-mortem examination. To respond adequately to newly introduced pathogens, part of the surveillance budget must be allocated with some flexibility, 
